Home » Aetna

Aetna

Jul 18, 2017

Castle Biosciences Uveal Melanoma Prognostic Test Garners Coverage from Multiple Payors

The company announced positive coverage decisions from Palmetto GBA, 14 BCBS plans, and Aetna.

Feb 09, 2017

Aetna to Cover NxGen MDx Genetic Testing Services

Starting Feb. 15, Aetna members will be able to access NxGen MDx's genetic screening and noninvasive prenatal testing as an in-network benefit. 

Jan 04, 2017

GenomeWeb Index Falls 3 Percent in 2016; Genmark Leads Gainers as PacBio Drops

It was a rough year for biotech stocks — the Nasdaq Biotech Index fell 22 percent even as the Dow gained 13 percent and the Nasdaq gained 8 percent.

Dec 08, 2016

Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

The new agreement brings Interpace's total insurance coverage for its thyroid assays to approximately 200 million patients.

Jun 26, 2015

Veracyte Thyroid Cancer Test Added to Aetna's Laboratory Network

The test differentiates benign thyroid nodules from cancerous ones.

Jul 07, 2014

Aetna Begins Coverage of CardioDx's Coronary Artery Disease Test

NEW YORK (GenomeWeb) – CardioDx today announced that Aetna has established a clinical policy for the Corus CAD gene expression test for coronary artery disease.

Apr 04, 2014

Aetna Policy Bulletin Indicates Insurer Unlikely to Cover Most Proteomic Cancer Tests

Premium

Insurer Aetna last month released a clinical policy bulletin providing an assessment of various available molecular-based cancer diagnostics and markers.

Apr 02, 2014

MDx/CDx Focus: 23andMe Still Working with FDA; Aetna Lists Medically Necessary, Investigational Dx

Premium

While Working with FDA, 23andMe Offers Customers No Timeline for Reporting Health-related Results

May 09, 2013

NIH Funds USF, Aetna to Study BRCA Testing

NEW YORK (GenomeWeb News) – The University of South Florida will use a $2.8 million grant from the National Institutes of Health to partner with Aetna and patient advocates to study how genetic testing for breast cancer risk can impact clinical decisions made by patients and doctors.

Feb 07, 2013

Aetna Throws Support Behind Non-invasive Prenatal Tests for Down Syndrome

NEW YORK (GenomeWeb News) – Aetna this week issued a clinical policy bulletin suggesting that it may soon begin covering non-invasive prenatal DNA tests for Down syndrome.

Pages

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.